focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCC Regulatory News (DCC)

Share Price Information for DCC (DCC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5,835.00
Bid: 5,500.00
Ask: 6,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (12.727%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 5,835.00
DCC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding in Company - TR-1

25 Sep 2013 12:51

RNS Number : 8828O
DCC PLC
25 September 2013
 



 

 

Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC[i]

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached [ii]:

DCC plc

2. Reason for the notification (please tick the appropriate box or boxes):

[ x] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation[iii]:

Mawer Investment Management Ltd.

4. Full name of shareholder(s) (if different from 3.)[iv]:

5. Date of the transaction and date on which the threshold is crossed or reached[v]:

September 18, 2013

6. Date on which issuer notified:

September 24, 2013

7. Threshold(s) that is/are crossed or reached: 3%

8. Notified details:

 

 

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii]

Number of Shares[viii]

Number of Voting rights[ix]

Number of shares[x]

Number of voting rights[xi]

% of voting rights

Direct

Direct[xii]

Indirect[xiii]

Direct

Indirect

Ordinary Shares

2,507,316

2,507,316

2,527,465

2,527,465

3.02%

SUBTOTAL A (based on aggregate voting rights)

2,507,316

2,507,316

2,527,465

2,527,465

3.02%

 

B) Financial Instruments

Resulting situation after the triggering transaction[xiv]

Type of financial instrument

Expiration Date[xv]

Exercise/Conversion Period/ Date[xvi]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

SUBTOTAL B (in relation to all expiration dates)

 

Total (A+B)

number of voting rights

% of voting rights

2,527,465

3.02%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instrumentsare effectively held, if applicable[xvii]:

N/A

10. In case of proxy voting:[name of the proxy holder] will cease to hold [number] voting rights as of [date].

11. Additional information:

Done at Calgary, Alberta, Canada on 25 September 2013.

 

 

Annex to the standard form TR-1 [xviii]

a) Identity of the person or legal entity subject to the notification obligation:

Full name (including legal form for legal entities)

Mawer Investment Management Ltd..

Contact address (registered office for legal entities)

900, 603 - 7th Avenue SW, Calgary, Alberta, T2P 2T5

Phone number

+1 (800) 889-6248

Other useful information (at least legal representative for legal persons)

…………………………………………….

b) Identity of the notifier, if applicable[xix]:

Full name

Paul Moroz

Contact address

900, 603 - 7th Avenue SW, Calgary, Alberta, T2P 2T5

Phone number

+1 403 267 1969

Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation)

Portfolio Manager

c) Additional information

 

 

Notes to Form TR-1

 


[i] This form is to be sent to the issuer or underlying issuer and to be filed with the competent authority.

 

[ii] Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.

 

[iii] This should be the full name of (a) the shareholder; (b) the natural person or legal entity acquiring, disposing of or exercising voting rights in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC; (c) all the parties to the agreement referred to in Article 10 (a) of that Directive, or (d) the holder of financial instruments entitled to acquire shares already issued to which voting rights are attached, as appropriate.

 

In relation to the transactions referred to in points (b) to (h) of Article 10 of that Directive, the following list is provided as indication of the persons who should be mentioned:

 

- in the circumstances foreseen in letter (b) of Article 10 of that Directive, the natural person or legal entity that acquires the voting rights and is entitled to exercise them under the agreement and the natural person or legal entity who is transferring temporarily for consideration the voting rights;

 

- in the circumstances foreseen in letter (c) of Article 10 of that Directive, the natural person or legal entity holding the collateral, provided the person or entity controls the voting rights and declares its intention of exercising them, and natural person or legal entity lodging the collateral under these conditions;

 

- in the circumstances foreseen in letter (d) of Article 10 of that Directive, the natural person or legal entity who has a life interest in shares if that person or entity is entitled to exercise the voting rights attached to the shares and the natural person or legal entity who is disposing of the voting rights when the life interest is created;

 

- in the circumstances foreseen in letter (e) of Article 10 of that Directive, the controlling natural person or legal entity and, provided it has a notification duty at an individual level under Article 9, under letters (a) to (d) of Article 10 of that Directive or under a combination of any of those situations, the controlled undertaking;

 

- in the circumstances foreseen in letter (f) of Article 10 of that Directive, the deposit taker of the shares, if he can exercise the voting rights attached to the shares deposited with him at his discretion, and the depositor of the shares allowing the deposit taker to exercise the voting rights at his discretion;

 

- in the circumstances foreseen in letter (g) of Article 10 of that Directive, the natural person or legal entity that controls the voting rights;

 

- in the circumstances foreseen in letter (h) of Article 10 of that Directive, the proxy holder, if he can exercise the voting rights at his discretion, and the shareholder who has given his proxy to the proxy holder allowing the latter to exercise the voting rights at his discretion.

[iv] Applicable in the cases provided for in Article 10 (b) to (h) of Directive 2004/109/EC. This should be the full name of the shareholder who is the counterparty to the natural person or legal entity referred to in Article 10 of that Directive unless the holdings of the shareholder would be lower than 5% of the total number of voting rights.

 

[v] The date of the transaction should normally be, in the case of an on exchange transaction, the date on which the matching of orders occurs; in the case of an off exchange transaction, date of the entering into an agreement. 

 

The date on which threshold is crossed should normally be the date on which the acquisition, disposal or possibility to exercise voting rights takes effect. For passive crossings, the date when the corporate event took effect.

 

[vi] Please refer to the situation disclosed in the previous notification. In case the situation previous to the triggering transaction was below 3%, please state "below 3%".

 

[vii] If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

 

For the case provided for in Article 10(a) of Directive 2004/109/EC, there should be no disclosure of individual holdings per party to the agreement unless a party individually crosses or reaches an Article 9 threshold. This applies upon entering into, introducing changes to or terminating an agreement.

 

[viii] To be used in Member States where applicable.

 

[ix] Direct and indirect.

 

[x] To be used in Member States where applicable.

 

[xi] In case of combined holdings of shares with voting rights attached "direct holding" and voting rights "indirect holding", please split the voting rights number and percentage into the direct and indirect columns - if there is no combined holdings, please leave the relevant box blank.

 

[xii] Voting rights attached to shares held by the notifying party (Article 9 of Directive 2004/109/EC).

 

[xiii] Voting rights held by the notifying party independently of any holding of shares (Article 10 of Directive 2004/109/EC).

 

[xiv] If the holding has fallen below the minimum threshold, the notifying party should not be obliged to disclose the extent of the holding, only that the new holding is below 3%.

 

[xv] Date of maturity/expiration of the financial instrument i.e. the date when right to acquire shares ends.

 

[xvi] If the financial instrument has such a period - please specify this period - for example once every 3 months starting from [date].

 

[xvii] The notification should include the name(s) of the controlled undertakings through which the voting rights are held. The notification should also include the amount of voting rights and the percentage held by each controlled undertaking, insofar as individually the controlled undertaking holds 3% or more, and insofar as the notification by the parent undertaking is intended to cover the notification obligations of the controlled undertaking.

 

[xviii] This annex is only to be filed with the competent authority.

 

[xix] Whenever another person makes the notification on behalf of the shareholder or the natural person/legal entity referred to in Articles 10 and 13 of Directive 2004/109/EC

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLNKPDQDBKDFCB
Date   Source Headline
10th Nov 20207:00 amRNSResults for the six months ended 30 September 2020
4th Nov 20204:35 pmRNSHolding in Company TR-1
29th Oct 20207:15 amRNSDirector Declaration
23rd Oct 20204:30 pmRNSHolding in Company TR-1
23rd Oct 20209:38 amRNSUpcoming Events
19th Oct 20203:51 pmRNSHolding in Company TR-1
14th Oct 20204:16 pmRNSHolding in Company TR-1
6th Oct 20203:40 pmRNSHolding in Company TR-1
5th Oct 202012:29 pmRNSHolding in Company TR-1
5th Oct 20209:30 amRNSHolding in Company TR-1
1st Oct 20205:07 pmRNSHolding in Company TR-1
22nd Sep 20204:29 pmRNSHolding in Company TR-1
21st Sep 20207:00 amRNSDCC expands LPG business in the US and Netherlands
9th Sep 20203:18 pmRNSAppointment of General Counsel & Company Secretary
4th Sep 20204:10 pmRNSUpdate on LTIP Performance Condition Ranges
31st Jul 202012:52 pmRNSTotal Voting Rights
23rd Jul 20204:14 pmRNSHolding in Company TR-1
21st Jul 202011:42 amRNSDirector/PDMR Shareholding
20th Jul 20204:00 pmRNSHolding in Company TR-1
17th Jul 20201:59 pmRNSResult of AGM
17th Jul 20207:00 amRNSInterim Management Statement
14th Jul 20202:28 pmRNSHolding in Company TR-1
8th Jul 202011:38 amRNSHolding in Company TR-1
24th Jun 20209:39 amRNSHolding in Company TR-1
18th Jun 202012:25 pmRNS2020 Annual Report, Notice of AGM and Proxy Form
3rd Jun 202010:10 amRNSHolding in Company TR-1
29th May 202011:27 amRNSTotal Voting Rights
28th May 20206:21 pmRNSDirector/PDMR Shareholding
28th May 20201:02 pmRNSHolding in Company TR-1
19th May 20205:04 pmRNSBoard Changes
19th May 20207:00 amRNSResults for the year ended 31 March 2020
14th May 20203:30 pmRNSHolding in Company TR-1
27th Apr 20206:02 pmRNSDisclosure of Rights Attached to Equity Shares
16th Apr 20204:24 pmRNSDirector Declaration
9th Apr 20204:21 pmRNSHolding in Company TR-1
3rd Apr 20204:01 pmRNSHolding in Company TR-1
25th Mar 20203:22 pmRNSHolding in Company TR-1
25th Mar 20207:00 amRNSDCC Healthcare announces acquisition of Amerilab
19th Mar 20204:10 pmRNSHolding in Company TR-1
19th Mar 20209:46 amRNSHolding in Company TR-1
18th Mar 202012:14 pmRNSHolding in Company TR-1
6th Mar 20204:08 pmRNSHolding in Company TR-1
28th Feb 202010:54 amRNSTotal Voting Rights
24th Feb 20208:38 amRNSBoard Change
24th Feb 20208:34 amRNSChief Financial Officer Succession
12th Feb 20209:10 amRNSHolding in Company TR-1
4th Feb 20207:00 amRNSInterim Management Statement
17th Jan 20209:23 amRNSHolding in Company TR-1
3rd Jan 202010:03 amRNSHolding in Company - TR1
23rd Dec 201912:44 pmRNSHolding in Company TR-1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.